porcin
circoviru
type
belong
famili
circovirida
small
nonenvelop
viru
circular
singlestrand
dna
genom
primari
caus
agent
porcin
circovirusassoci
diseas
pcvad
global
emerg
diseas
current
caus
great
econom
loss
global
swine
industri
today
signific
patholog
condit
consid
pcvad
postwean
multisystem
wast
syndrom
porcin
dermat
nephropathi
syndrom
diseas
piglet
readili
contract
concomit
infect
includ
porcin
respiratori
reproduct
syndrom
viru
porcin
parvoviru
haemophilu
parasui
suggest
pcvad
actual
immunosuppress
diseas
besid
piglet
mice
calv
also
found
abl
infect
viru
control
pcvd
base
manag
strategi
control
coinfect
vaccin
vaccin
tradit
consid
effect
method
prevent
viral
diseas
period
protect
afford
vaccin
limit
viru
erad
vaccin
furthermor
effect
vaccin
avail
prevent
multifactori
diseas
pcvad
therefor
altern
effect
measur
control
diseas
urgent
requir
import
molecul
key
role
broad
rang
biolog
process
includ
neurotransmiss
vasodilat
immun
respons
gener
mammalian
cell
guanidino
nitrogen
larginin
reaction
catalyz
famili
synthas
enzym
also
releas
exogen
donor
sodium
nitroprussid
snp
snitrosoacetylpenicillamin
snap
gsno
previou
studi
present
consider
evid
prevent
viral
infect
howev
antivir
effect
infect
far
poorli
studi
studi
nogener
compound
gsno
use
analyz
kinet
product
cultur
supernat
cell
antivir
activ
mediat
gsno
infect
also
investig
cell
balbc
mice
pcvfree
cell
purchas
china
institut
veterinari
drug
control
beij
china
grown
atmospher
dulbecco
modifi
eagl
medium
dmem
sigma
usa
supplement
fetal
bovin
serum
gibco
usa
penicillinstreptomycin
antibiot
sangon
china
strain
genbank
access
number
maintain
institut
veterinari
medicin
jiangsu
academi
agricultur
scienc
jiangsu
china
propag
cell
harvest
incub
h
store
use
safe
concentr
drug
determin
cell
bromid
mtt
assay
kinet
product
cultur
supernat
assess
h
drug
treatment
investig
antivir
activ
nogener
compound
gsno
infect
vitro
confluent
cell
cell
cultur
plate
pretreat
gsno
gsno
plu
hemoglobin
hb
h
infect
multipl
infect
moi
presenc
drug
addit
h
untreat
cell
cultur
medium
alon
use
mock
control
cell
infect
alon
moi
use
control
antivir
activ
gsno
determin
appear
cell
viral
titer
dna
copi
number
level
variou
group
also
determin
seventyeight
specificpathogenfre
balbc
mice
purchas
compar
medicin
centr
yangzhou
univers
jiangsu
china
mice
maintain
isol
room
temperatur
maintain
light
cycl
experiment
anim
allow
acclimat
day
protocol
care
use
anim
studi
approv
committe
ethic
anim
experi
jiangsu
academi
agricultur
scienc
mice
randomli
divid
three
group
contain
anim
mice
group
inject
intraperiton
ml
phosphatebuff
salin
pb
intranas
ml
pb
use
neg
control
nc
mice
group
ii
inocul
intraperiton
ml
intranas
ml
use
control
mice
group
iii
inocul
intraperiton
ml
intranas
ml
inject
intraperiton
ml
gsno
mm
daili
day
postinocul
dpi
exclud
stress
induc
inject
mice
group
ii
also
inject
intraperiton
ml
pb
daili
dpi
dpi
mice
weigh
necropsi
perform
four
mice
group
dpi
blood
sampl
withdrawn
orbit
venou
plexu
mous
isol
serum
detect
time
necropsi
serum
sampl
tissu
sampl
collect
store
polymeras
chain
reaction
pcr
realtim
pcr
spleen
thymu
kill
mous
weigh
calcul
organ
index
mice
monitor
daili
evalu
clinic
sign
throughout
trial
studi
use
gsno
sigma
usa
exogen
donor
hb
sigma
usa
scaveng
scaveng
releas
gsno
cytotox
drug
evalu
mtt
assay
brief
cell
seed
cell
cultur
plate
densiti
cellswel
cell
well
reach
confluenc
wash
twice
pb
treat
differ
concentr
drug
serial
twofold
dilut
eight
well
concentr
incub
h
viabil
cell
evalu
colorimetr
mtt
assay
report
previous
absorb
nm
well
measur
microlit
enzymelink
immunosorb
assay
reader
sunris
tecan
co
switzerland
product
measur
colorimetr
assay
use
griess
reaction
briefli
variou
time
point
cell
cultur
supernat
harvest
incub
equal
volum
griess
solut
sulfanilamid
naphthyl
ethylen
diamin
dihydrochlorid
phosphor
acid
sigma
usa
min
room
temperatur
absorb
read
nm
concentr
determin
least
squar
linear
regress
analysi
standard
curv
sodium
nitrit
ifa
perform
accord
previous
describ
procedur
brief
cell
fix
frozen
methanol
min
fix
cell
wash
pb
incub
porcin
antibodi
vmrd
usa
h
cell
wash
pb
incub
fitcconjug
goat
antipig
antibodi
abcam
uk
min
wash
pb
examin
fluoresc
microscop
olympu
japan
cell
posit
viral
antigen
count
six
field
view
sampl
collect
cell
cultur
plate
frozen
thaw
three
time
serial
dilut
dmem
cell
seed
plate
cell
well
reach
confluenc
inocul
dilut
sampl
eight
well
use
dilut
incub
h
sampl
detect
ifa
mention
viral
titer
calcul
reedmuench
method
dna
extract
use
column
viral
dnaout
kit
tiandz
beij
china
accord
manufactur
instruct
total
dna
store
use
evalu
viremia
viral
load
tissu
mice
pair
primer
design
base
publish
sequenc
forward
primer
revers
primer
pcr
perform
thermal
cycl
paramet
min
follow
cycl
min
min
min
final
extens
step
min
pcr
product
subject
electrophoresi
agaros
gel
analyz
viral
dna
copi
number
cell
serum
sampl
primer
taqman
probe
specif
sequenc
design
forward
primer
revers
primer
taqman
probe
aatggcatcttcaacacccgcctct
tamra
taqmanbas
realtim
pcr
perform
realtim
pcr
system
appli
biosystem
usa
use
thermal
cycl
paramet
cycl
differ
among
differ
treatment
group
analyz
compar
oneway
analysi
varianc
anova
follow
leastsignific
differ
test
use
statist
packag
spss
ver
window
valu
p
consid
statist
signific
shown
fig
valu
cell
treat
gsno
differ
significantli
control
cell
mtt
assay
p
therefor
gsno
use
safe
concentr
cell
studi
safe
concentr
hb
cell
determin
fig
determin
kinet
product
supernat
sampl
cell
cultur
plate
collect
differ
time
point
drug
treatment
level
assay
griess
reaction
product
significantli
higher
gsnotreat
group
without
infect
control
group
p
fig
level
tend
increas
gsnotreat
group
h
drug
treatment
reach
plateau
around
h
fig
howev
gener
gsno
effect
dosedepend
scaveng
noscaveng
hb
fig
inhibitori
effect
nogener
compound
gsno
replic
shown
fig
cell
detect
ifa
indic
treatment
gsno
reduc
progress
infect
fig
percentag
cell
decreas
treatment
gsno
rel
infect
control
p
fig
wherea
percentag
cell
group
incub
gsno
plu
hb
respect
fig
viral
titer
viral
dna
copi
number
group
decreas
significantli
gsno
treatment
rel
control
p
p
fig
e
howev
reduct
viral
titer
viral
dna
copi
number
induc
gsno
dosedepend
revers
scaveng
hb
fig
e
mice
surviv
inocul
without
gsno
treatment
none
mice
clinic
affect
studi
obviou
gross
lesion
tissu
experiment
anim
gsno
treatment
caus
signific
increas
serum
level
mice
infect
p
fig
shown
fig
averag
daili
weight
gain
adwg
tend
decreas
control
mice
dpi
lower
nc
mice
p
howev
adwg
mice
treat
gsno
significantli
higher
control
mice
p
dpi
analysi
kinet
spleen
index
si
thymu
index
ti
demonstr
gsnoinduc
improv
mous
spleen
thymus
infect
dpi
shown
fig
c
si
ti
significantli
higher
gsnotreat
mice
dpi
untreat
mice
infect
p
p
si
control
mice
also
decreas
significantli
dpi
compar
nc
mice
p
p
fig
wherea
ti
decreas
significantli
control
mice
dpi
p
fig
howev
signific
differ
si
ti
gsnotreat
mice
nc
mice
dpi
p
throughout
experi
serum
sampl
obtain
nc
mice
neg
nucleic
acid
analyz
gelbas
pcr
quantit
realtim
pcr
assay
mice
dna
detect
gelbas
pcr
pool
tissu
sampl
serum
sampl
dna
determin
tissu
sampl
serum
sampl
control
mice
dpi
tabl
howev
percentag
tissu
sampl
serum
sampl
gsnotreat
mice
infect
respect
tabl
signific
differ
also
note
tissu
sampl
p
serum
sampl
p
control
mice
mice
treat
gsno
tabl
describ
fig
number
dna
copi
reach
plateau
dpi
declin
extent
dpi
mice
treat
without
gsno
howev
dpi
number
dna
copi
xwa
significantli
lower
mice
treat
gsno
time
point
compar
control
mice
p
fig
import
cellular
messeng
involv
complex
divers
function
variou
physiolog
patholog
process
display
broad
spectrum
antimicrobi
activ
vitro
vivo
studi
verifi
antivir
activ
nogener
compound
gsno
infect
cell
balbc
mice
vitro
experi
show
treatment
gsno
induc
signific
declin
cell
viral
titer
viral
dna
copi
number
compar
sampl
wherea
effect
gsno
dosedepend
revers
scaveng
hb
result
demonstr
donor
gsno
exert
signific
antivir
activ
replic
cell
similarli
previou
studi
donor
snap
shown
block
replic
sever
acut
respiratori
syndrom
coronaviru
sar
coronaviru
porcin
parvoviru
porcin
respiratori
coronaviru
although
inhibit
clearli
demonstr
unclear
whether
antivir
effect
donor
gsno
actual
attribut
factor
address
question
convinc
evid
present
studi
first
data
mtt
assay
clearli
exclud
possibl
antivir
effect
donor
gsno
replic
might
result
toxic
cell
second
gsno
gener
cultur
supernat
cell
dosedepend
suppress
replic
final
inhibitori
effect
gsno
replic
revers
scaveng
hb
overal
result
strongli
suggest
gener
donor
gsno
inhibit
replic
cell
mechan
involv
antivir
properti
partli
clarifi
previou
studi
suggest
play
import
role
regul
viral
proteas
innat
immun
host
synthesi
viral
protein
nucleic
acid
depend
concentr
exert
antimicrobi
effect
two
way
low
concentr
act
signal
molecul
promot
growth
activ
immun
cell
wherea
high
concentr
coval
bind
dna
protein
lipid
therebi
inhibit
kill
target
pathogen
antivir
activ
demonstr
vitro
reduct
number
virusinfect
cell
viral
titer
dna
copi
number
declin
number
viral
infect
cell
probabl
attribut
blockag
viral
penetr
cytoplasm
suppress
transcript
step
mediat
wherea
reduc
viral
titer
viral
dna
copi
number
probabl
attribut
inhibit
viral
protein
nucleic
acid
synthesi
howev
bind
cell
entri
transcript
characterist
influenc
investig
studi
therefor
mechan
underli
inhibit
replic
remain
evalu
futur
studi
although
antivir
activ
gsno
clearli
demonstr
vitro
vivo
studi
also
essenti
confirm
effect
gsno
infect
clinic
condit
mice
includ
balbc
kunm
mice
suscept
although
suscept
limit
among
abovement
mous
line
therefor
mous
import
epidemiolog
use
experiment
model
studi
balbc
mice
artifici
inocul
treat
without
gsno
data
show
gsno
treatment
releas
larg
amount
contribut
effect
inhibit
replic
mice
poor
growth
perform
immun
organ
spleen
thymu
dysfunct
induc
infect
also
improv
extent
gsno
previou
report
demonstr
dietari
larginin
supplement
induc
signific
increas
serum
product
suppress
infect
mice
suggest
antivir
effect
larginin
predominantli
mediat
larginin
sole
substrat
synthesi
hypothesi
confirm
vivo
studi
gsno
exogen
donor
releas
mice
although
weight
loss
wast
observ
mice
describ
previous
adwg
mice
infect
decreas
extent
present
studi
might
attribut
differ
mous
line
use
sinc
kiupel
et
al
demonstr
induc
apoptosi
activ
caspas
spleen
infect
mice
therefor
impair
immun
organ
detect
control
mice
studi
might
attribut
apoptosi
induc
interestingli
gsno
treatment
improv
growth
perform
protect
immun
organ
spleen
thymu
mice
know
act
key
molecul
inflamm
immun
respons
nogener
compound
gsno
may
play
critic
role
regul
inflamm
immun
infect
well
inhibit
replic
mice
research
requir
confirm
hypothesi
gsno
exogen
donor
releas
cultur
supernat
cell
sera
balbc
mice
antivir
effect
gsno
also
demonstr
cell
balbc
mice
well
signific
inhibit
gsno
also
posit
regul
growth
perform
immun
organ
mice
therefor
donor
gsno
potenti
valv
antivir
reagent
infect
howev
mechan
underli
antivir
activ
gsno
remain
investig
futur
studi
effect
gsno
infect
target
anim
pig
must
also
evalu
